Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio

Dyno Therapeutics launches Dyno-yp2, a top-performing TfR1-mediated AAV capsid, to further diversify CNS delivery portfolio ...

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

CASGEVY® launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading ...
Le Lézard

Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome

Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug ...

Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...
Pharmabiz

Avista Therapeutics expands AI gene therapy platform to break barriers in the delivery of genetic medicines

Avista Therapeutics expands AI gene therapy platform to break barriers in the delivery of genetic medicines: Pittsburgh Monday, January 12, 2026, 16:00 Hrs [IST] Avista Therapeuti ...

Top 50 CBSE Class 12 Biology MCQs with Answers for High Score in Pre Board Exam 2026

Top 50 CBSE Class 12 Biology MCQs with Answers based on CBSE previous year question papers for Pre Board Exam 2026 are ...